Supplementary Figure S7 from <i>NPY</i> Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer

<p>Copy number alteration (CNA) profile of patient 24 based on shallow whole-genome sequencing (sWGS) of the baseline cfDNA sample.</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Katleen Janssens (15053356) (author)
Diğer Yazarlar:	Greetje Vanhoutte (15053359) (author), Willem Lybaert (15053362) (author), Wim Demey (15053365) (author), Jochen Decaestecker (15053368) (author), Koen Hendrickx (15053371) (author), Hassan Rezaei Kalantari (15053374) (author), Karen Zwaenepoel (15053377) (author), Patrick Pauwels (15053380) (author), Erik Fransen (15053383) (author), Ken Op de Beeck (15053386) (author), Guy Van Camp (15053389) (author), Christian Rolfo (14936298) (author), Marc Peeters (15037311) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Cancer Risk Factors Molecular and Cellular Biology Cancer Detection and Diagnosis Clinical Research and Trials Biomarkers Circulating tumor cells/DNA/exosomes Epigenetic biomarkers Prognostic biomarkers Epigenetics DNA methylation Gastrointestinal Cancers Colorectal cancer Precision Medicine
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller